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ABSTRACT
There are important gaps in the health status of citizens across Europe, as measured
by life expectancy, mortality or morbidity data (Report for the European Commission
on the health status of the European Union, 2003). Among the main determinants of
the major causes of mortality and morbidity, stated in this report, stands recurrently
access to quality healthcare. There is a fundamental need to define quality indicators
and set minimal levels of performance quality criteria for healthcare. There is a need
to integrate research into healthcare and to provide patients with equity of access to
such high quality care. Oncology is a speciality particularly suited to experimenting a
first application of accreditation at European level.  The Organisation of European
Cancer Institutes is a growing network of cancer Centres in Europe. The focus of the
OECI is to work with professionals and organisations with regard to prevention, care,
research, development, patient’s role and education. In order to fulfil its mission, the
OECI initiated in 2002 an accreditation project with three objectives: 
• to develop a comprehensive accreditation system for oncology care, taking into
account prevention, care, research, education and networking.  
• to set an updated database of cancer centres in Europe, with exhaustive informa-
tion on their  resources and activities (in care, research, education and management)
• to develop a global labelling tool dedicated to comprehensive cancer centres in
Europe, designating the various types of cancer structures, and the comprehensive
cancer centres of reference and Excellence.
An accreditation tool has been established, defining standards and criteria for preven-
tion, care, research, education and follow-up activities. A quantitative database of can-
cer centres is integrated in the tool, with a questionnaire, that provides an overall view of
the oncological landscape in OECI cancer centres in Europe. Data on infrastructures, re-
sources and activities have been collected. This OECI accreditation tool will be launched
in autumn 2008 for all cancer centres in Europe. It serves as a basis for the development
of the labelling tool for cancer structures in Europe, with a focus on Comprehensiveness
and Excellence labels. Quality assessment and improvement is a critical need in Europe
and is addressed by the OECI for cancer care in Europe. Accreditation is a well accepted
process and is feasible. Standards and criteria as well as an accreditation tool have been
developed. The OECI questionnaire gives an accurate vision of cancer institutions
throughout Europe, helping assessing the needs and providing standards. The accredi-
tation project is a long-term complete and voluntary process with external and internal
added value, an active process of sharing information and experience that should help
the whole cancer community reach comprehensiveness and excellence.
Tumori, 94: 164-171, 2008
The context
Development of Health plans
Resources, financial and otherwise, vary greatly from
country to country and systems for providing medical
care are similarly varied, however research on health
care plans should help develop systems allowing to
meet certain common goals such as access to, and con-
tinuity of, quality care. 
Consensual standards and criteria for quality of care
are sought by health care professionals, especially for
emerging health care systems, as well as incentives and
processes for quality improvement.
Those criteria should cover clinical guidelines, but al-
so encompass the area of organisation and manage-
ment of the institution and of health care processes1.
Especially when interactions among various profes-
sionals are needed, for multidisciplinary care, or for in-
tegration and translation of research into care, a strong
framework for quality must be established, including
processes for team work or for interaction, in order to
allow all healthcare institutions take part in a global
quality improvement process.
Cancer is a worldwide health burden affecting both
the survival and quality of life of human beings. At Eu-
ropean level, huge efforts are being made for better co-
ordination and overall improvement of the research and
care in the cancer field. However, healthcare planning
in the cancer field is crucially and urgently needed in or-
der to better integrate these efforts and foster existing
initiatives2. Important funds are dedicated to research
and actions are taken to promote the translation of the
knowledge and innovation into care. Still, information
on quality of care standards and criteria, and access to
knowledge and information are unequally shared
throughout Europe. A common initiative of consensual
definition of quality criteria and standards, their dis-
semination and the evaluation of the adequacy of the
practices with the standards, should help harmonise
and improve care standards, both at the clinical level
and at the organisational and management level. This
would help ensure not only minimal safety conditions
of cancer care, but also improve access to high quality
health care and potentially stimulate optimal provision
of care integrating the best of knowledge (Figure 1).
In this context, a system establishing consensual and
common standards and criteria allowing both self eval-
uation of these criteria and external evaluation through
peer review should be tested for its ability to answer the
quality issue.
Access to information 
Patients should receive adequate information about
their illness, possible interventions, and the known ben-
efits and risks of specific treatment options. These mat-
ters should be discussed with qualified healthcare per-
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sonnel who are committed to responding forthrightly to
patient inquiries. Patients should have the ability to as-
certain names, roles and qualifications of those who are
treating them. 
Most of all, considering the potential mobility of pa-
tients in the European Community, patients should re-
ceive adequate information on the standards of care
and where they can receive adequate quality care, or in-
formation about care centres of reference and centres of
excellence. Therefore, a system providing updated peer-
reviewed mapping and sound information on recog-
nised centres of high quality care should be developed. 
Innovative cancer care 
Research progresses achieved in the fight against can-
cer should be translated into care, in order to improve
survival and quality of life of cancer patients. Patients
should be offered the opportunity to participate in rele-
vant clinical trials and should have access to innovative
therapies that might improve their disease outcome.  
Common vision 
There is a need to work towards a common vision of
European cancer activities: prevention, care, research,
development and education. It is important to create a
network sharing a consensual view of cancer activities
and with an integration of care and research. 
Quality and the cancer world
Quality issues in the cancer community (Figure 2) vary
from the different points of view of the cancer world.
• What do cancer centres / professionals need to improve
in terms of quality? 
– Consensual objective standards and criteria on how
high-quality cancer prevention / care / follow-up /
research / education should be performed
Figure 1 - Oncology specificities.
Complex and dynamic system
Particularly in need of quality standards  
and accreditation at European level
Multidisciplinary
Healthcare networks
Evaluated therapeutic protocols, care guidelines 
Global care of patients (supportive elements)
Synergy between surgery, radiotherapy, drug  
treatment, and follow-up care 
Evaluation of results (quality of life +++ survival +++) 
Integration of research 
=> Therapeutic Progress Therapeutic Progress
166 M SAGHATCHIAN, H HUMMEL, R OTTER ET AL
– A process of self evaluation of this quality
– A process of peer review of the quality
– Recognition of the quality (accreditation / labels)
– Measurements to compare: References for bench-
marking
• What should we give to our patients?
– Best of prevention / care / follow-up
– Proven interventions  at minimum risk
– Benefits from research
– Information on where to get the best
• What are health authorities lacking?
– A regulation system to ensure that we offer the pub-
lic better survival and quality of life
– A regulation system to allow efficient funding (espe-
cially of care and research)
• What are research funders seeking?
– Reference centres for fast and efficient research de-
velopment
– Safety assurance
The OECI accreditation project. 
A cancer quality project
Principles
The mission of the Organisation of European Cancer
Institutes (OECI) is to serve as a linking organisation,
coordinating interdisciplinary cancer treatment and
improving the quality of cancer care.  This can be
achieved by integrating cancer prevention, research and
development and cancer education3.
Consequently, the OECI launched the Accreditation
Project in September 2005, and gave mandate to the Ac-
creditation Working Group (AWG) to lead this project.  
The OECI AWG involved scientists, forming a diverse,
coordinated and integrated network with the following
relevant characteristics:
• Ability to address different disciplinary aspects. Part-
ners are scientific experts who are involved in everyday
specialised patient care and are participating in med-
ical care and research, in healthcare institutions man-
agement, and researchers from national agencies in-
volved in healthcare assessment or health insurance.
• Integration of activities and research through the in-
volvement of a common steering committee at every-
decision-making step.
• Evidence-based design after evaluation of the cur-
rently used performance assessment system after in-
depth inventory and comparison. 
• Demand-driven through the involvement of patient
groups and professionals providing care.
• Comprehensive, by taking into account various types
of procedures aimed at improving quality (accredita-
tion systems, clinical guidelines implementation sys-
tems, regulation and legislations); and by considering
systems in both Member States and third countries;
and by using results from ongoing research per-
formed by other organisations.
• Informative, by ensuring systematic analysis and re-
porting of data with web-based dissemination and
stakeholders’ involvement.
• Innovative, with the systematic research on imple-
mentation through information technologies.
The Creation of a European accreditation programme
for Cancer Structures within the OECI is focused on the
key issues for quality comprehensive cancer care struc-
tures: i.e. the rapid translation of results from research
into daily practice and the total and global quality man-
agement of the cancer patient during his lifetime.
The OECI Accreditation tool
The AWG’s preliminary work was to review existing
options in order to complete the creation of a European
accreditation programme and consensually choose the
quality credentials and criteria relevant to improving
cancer care throughout Europe.  
The AWG discussed the numerous challenges for Eu-
rope regarding the creation of a consensus on the defi-
nition of quality care. In this respect, European OECI
member countries share many of the same differences
such as population, technology, national regulations,
cultural habits and language. The OECI wishes to link
European countries, define their qualities, improve
their research and construct quality comprehensive
cancer care centres.  
Special focus was made on specific oncology key as-
pects such as multidisciplinarity, global care, integra-
tion of research, networking and patients involvement.
Considering these prerequisites, the AWG established:
– standards and criteria for quality multidisciplinary
cancer care delivered in cancer centres throughout
Europe (Quality Manual), 
Figure 2 - The cancer world.
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– a process allowing to survey the cancer centres in
order to assess compliance with those standards, 
– a quantitative questionnaire measuring the re-
sources and activities in the cancer centres,
– a tool to collect standardised and quality data from ap-
proved cancer centres, to measure treatment patterns
and outcomes. The tool is translated into an electron-
ic format (OECI accreditation e-Tool, Figure 3).
The Quality Manual is composed of several chapters:
• General standards, strategic plan and general man-
agement (19)
• Screening, primary prevention and health education (7)
• Care (9)
• Research, innovation and development (12)
• Teaching and continuing education (4)
• Patient section (7)
Each chapter is divided into sections:
• Policy and organisation
• Process control
• Resources and materials
• Knowledge and skills
• Safeguarding the quality system
The qualitative questionnaire covers data regarding
all the resources and activities of the cancer centre as
shown in Table 1.
Both the quality manual and the quantitative ques-
tionnaire are translated into an e-Tool.
Table 1 - Quantitative Questionnaire (database)
General content
Type of centre/institute
Population base
Infrastructures – care
Human resources
Clinical care
Research
Education
Institutional structures and budgets
Infrastructures for cancer care
Inpatient beds
Outpatient beds
Radiotherapy
Surgery
Haematology
Intensive care
Screening-early detection
Palliative care
Psychosocial oncology
Rehabilitation
Pain treatment
Nuclear medicine
Cytology/histopathology
Tumour bank
Transfusion centre
Bone marrow bank
Central pharmacy
Quality assurance unit
(continued)
Table 1
Human resources
Number of employees
Specialised doctors
Nurses 
Engineers, physics
Technicians
Dieticians
Psychologists
Pharmacists
Physicists
Clinical care activities
Prevention 
Screening
Genetic counselling
Multidisciplinary teams
Care programmes
Number of new pts
Outpatient visits
Day care
Inpatients
Duration of stay
Chemotherapy
Radiation therapy
Bone marrow/stem cell transplantations
Surgical procedures
Tumour pathological diagnoses
Patient waiting time
Research activities 
Animal host facilities
Biomics
Tumour bank
R&D unit
SME contact
Biostatistics
Epidemiology
Health economy
Ethical review committee
Clinical trial unit
Translational research
Clinical trial activities
University affiliation
Research collaboration
Research staff
Scientific publications
Research funding
Education
Information centre for patients
Medical library
Education courses
Students: basic, specialist, research
Academic positions
Exchange programme
CME
PhD thesis
Educational programmes for patients
Educational activities for decision makers
Institutional structure and budget
Administrative status, academic, public, private etc
Coordination of cancer care
Part of network
International affairs department
Budget health care
Budget research
Budget education
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Development of this innovative information technol-
ogy tool has been assigned to a professional SME, Com-
pusense, which closely interacts with the AWG for the
translation into an IT tool that would be user-friendly
for inexperienced healthcare professionals, while allow-
ing sound reporting and statistical analysis of data.
Compusense is an appropriate partner for its specific
expertise in International cooperation and on the Euro-
pean market since it has extensive experience in au-
tomating accreditation systems for professionals, e.g.,
for NIAZ (Netherlands accreditation organization for
hospitals) and for the Danish accreditation organiza-
tion.
The e-tool plays an important role in the question-
naire format for OECI members’ participation in the ac-
creditation process. The web-based tool is a secure site
for member use only.
The OECI accreditation process
The AWG obtained the commitment of 8 volunteer
centres for two pilot phases on the understanding, fea-
sibility and adaptability of the assessment tool.
The first pilot aimed at checking and improving the
standards, criteria and the items quantitative question-
naire.
Once the criteria and norms were adjusted, methods
through which hospitals and professionals can check
what they must improve to reach the required level of
care delivery (self-evaluation model) were developed
and assessed in a second pilot.
Still in the works, the second pilot of the e-tool is in-
tended to validate the peer-review system and hence
create an evaluation tool, which could provide audit
recommendations for improvement.
Besides a self-evaluation tool it is necessary to devel-
op an accreditation method. Impartial auditors who will
be able to identify those elements within the organiza-
tion, which should be improved, will look at the care de-
livery. It will also be possible to compare one’s own or-
ganization to others accredited organisations. Compar-
ing with others gives the opportunity to learn from each
other and in consequence to improve one’s care deliv-
ery. The goal is to reach such a level of care delivery in
Europe that, throughout Europe, patients will have the
guarantee that oncological care is in accordance with
European standards4-5.
The results of this second pilot will allow finalizing the
tool and preparing for dissemination at European level.
The good progress made to date by the AWG should
allow starting the OECI accreditation process for all OE-
CI members in autumn 2008.
The 2008 Genoa OECI General Assembly is thus a
unique opportunity for the AWG to present and dis-
cuss the Accreditation Programme designed for OECI
members (Figure 4).Figure 3 - The OECI accreditation e-tool.
Electronic OECI
accreditation tool
(Web-based) 
Standards and criteria (qualitative questionnaire) 
+ scoring system based on compliance level
+ Quantitative questions  
Translated into             an electronic manual 
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Further developments
General perspective
Guidelines for diagnosis and care facilitate collabora-
tion in clinical research. Harmonisation strategies for
the different cancer centres in combination with im-
proved communication and educational programmes
will increase collaboration and sharing of common fa-
cilities. An important goal of the programme is in-
creased integration between cancer care and research.
Improving overall quality of cancer centres as well as
harmonization and quality assurance of the infrastruc-
ture for translational research will, with OECI as a
frame, increase communication and collaboration be-
tween European cancer institutes. The work will start
with the linkage of a few cancer centres to establish
“good examples or best practices”. More collaboration
between cancer centres will increase the possibilities to
elaborate interesting research plans with further
chances to receive economic support from the funding
programmes of the EU.
Eventually, the data could be used to evaluate cancer
centres performances and develop effective systems
and interventions that will allow us to improve cancer
care outcomes at the national and European level6.
Integration of research is a global policy issue.
There is an urgent need for bridging the gap between
basic research and clinical practice, to allow a fast trans-
lation of the outstanding progress achieved in basic re-
search into new diagnostic tools, new treatments and
new technologies dedicated to prevention care or reha-
bilitation. However, such rapid translational process is
hampered by various structural elements:
– National health systems, with lack of structural
process for the development of innovation
– Financial constraints in the health system: another
structural brake regarding innovation
There are major inequalities in Europe and within
each member state for access to high quality care updat-
ed to the most recent developments. Innovation actual-
ly concerns a small minority of patients (less than 5% of
European Cancer patients have access to clinical trials).
Efficient transfer of new concepts - new tools - new
technologies towards diagnosis and treatment requires
the development of specialised skills in Genetics, Ge-
nomics, New technologies: Imaging, Physics, Bioinfor-
matics, Social sciences, and Economics.
There is, in this context, a need for the rapid develop-
ment of new diagnostic markers, new targets for thera-
py, new methodologies for clinical trials, new endpoints
(functional imaging), and new rules of the game with
the industry (Figure 5).
The fundamental achievement would be a new deal
with informed patients/citizens seen as real partners for
research. Quality improvement strategies should inte-
grate this fundamental dimension and allow identifica-
An Objective : Quality of cancer care 
A Goal :  More Comprehensiveness
The challenge : Assessment / Validation
A project : The OECI Accreditation
Project
A tool : OECI Acc. Tool
Validation of tool / Acceptance
Dissemination to OECI Centres
Definition of Cancer Care 
structures
Definition of Comprehensive Cancer 
structures (of Excellence)
Labelisation
Validation through quality indicators
Link quality to outcome / Benchmark
INTERNAL DEVELOPMENTS
38EXTERNAL DEVELOPMENTS
Links with
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International 
Links (US, 
Canada) 
EU 
recognition
In depth
Tumour 
Specific
Accreditation
In depth
Professional 
Accreditation
National 
Application
Patients 
Information
Public 
Reporting
Driving
Industrial
strategy
OECI
Accreditation
inform the authorities, 
public and the patients 
about the results of the 
process.
facilitate the sharing of 
expertise between the 
accredited centres of reference 
and other centres and hospitals
Figure 5 - Developments.
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tion and promotion of reference basic research centres
and translational reference research centres to make all
changes in cure and survival available to patients
throughout Europe7.
Implementation of the OECI performance tool, par-
ticularly in the context of oncology, which is a critical
example of these issues, will identify ways of integrating
this additional layer of quality care in the overall assess-
ment of institutions.
Labelling of cancer structures
The AWG’s plan is to build a long-term complete and
voluntary process with external and internal added val-
ue. It should become an active process of sharing infor-
mation and experience. 
It is important to define common tools for auto eval-
uation that are not daunting and have been created with
a set of guidelines agreed by peers and colleagues.
The definition and scoring of the various types of can-
cer structures will help improve the status of all partici-
pating Centres. 
Within this background, the AWG is also developing  a
labelling system of the different cancer institutes / cen-
tres and for Comprehensive Cancer Centres of Excel-
lence organised centrally or as a network.
At this stage, the following key issues will be ad-
dressed: are the centres only focused on treatment? Do
they participate in education, basic research and trans-
lational research with a continuum of clinical and basic
research?  
There needs to be agreement on the quality of the re-
search process and its integration into the daily activi-
ties of the centres. Clinical research and participation in
clinical trials and the evaluation of the quality of the da-
ta is also part of the quality process.
Collaborations 
With all the topics and areas involved in the AWG pro-
gramme, collaboration with external partners is needed.
Therefore, the AWG has enlisted the help of other organ-
isations in Europe active in good clinical practice such as
ESMO (European Society of Medical Oncology), EORTC
(European Organisation for Research and Treatment of
Cancer), ESTRO (European Society for Therapeutic Radi-
ology and Oncology) ESSO (European Society of Surgical
Oncology), EONS (European Oncology Nursing Society),
Eusoma Breast Cancer Units, CoCanCPG project and
many others, especially patient’s organisations which
should be at the centre of the project.
To illustrate the OECI’s work towards completing its
accreditation programme, the AWG is inviting interna-
tional experts to provide input in the process. The US
and Canadian systems and experiences are a great con-
tribution.
Moreover, close interactions with national coordinat-
ing structures is key for the implementation and dis-
semination of the process; for instance, the French Fed-
eration of Cancer Centres and the Alleanza Contro il
Cancro are key partners that support strongly the initia-
tive and ease the process by creating a direct and effi-
cient link with all the cancer centres in France and Italy.
Dissemination, education
As the networking process is very important, the or-
ganisation provides constant efforts in order to facilitate
the sharing of expertise between the various stakehold-
ers and cancer professionals in Europe. 
For accredited centres to maintain their status and in or-
der to give the opportunity to other centres to improve
and/or become a partner in the networking process, the
AWG organises appropriate educational activities, espe-
cially training sessions on the electronic tool for self-evalu-
ation, and auditors training for peer review. 
Moreover, a communication strategy will be set up to
inform the authorities, the public and the patients
about the results of the process.
Conclusion
In the end, among the potential benefits of such a
project, the most immediate ones are: 
• improved care to individuals
• strengthened community confidence in the quality of
continuous care in the hospital
• healthcare professional education
• stimulation of quality improvement efforts if the ac-
creditation recommendations are implemented after
the accreditation process
• objective evaluation of the hospital’s quality of care
• potential for improved liability insurance coverage
• comparative assessment of care structures
• provision of a more coherent overall vision with a
clear evidence base
• reporting to the public
• increased harmonisation and equity for patients8
Moreover, the evaluation of cancer structures can
serve as a basis for the evaluation and accreditation of
different specialities linked to cancer care, such as sur-
gery, radiation therapy, imaging techniques, rehabilita-
tion structures, outcome measurement, and health reg-
istries. It covers thus different disciplinary aspects.
Collecting and selecting minimum standards for
quality healthcare is aimed at providing transparent
and visible information to citizens and evidence-based
data for informed access to healthcare institutions, as a
right of the citizens of the EU.
It should also provide guidance and help for healthcare
institutions located within Member States lacking per-
formance assessment structures in order to reduce in-
equalities, provide equity and allow mobility of patients.
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The OECI accreditation project will be implemented
in a way that allows consultation and participation of
healthcare providers and consumers in a balanced way,
thus enabling a deeper involvement of individuals in
the design of policy strategies concerning their health
and well-being.
The accreditation tool is designed for internal use by
health care organisations to support performance im-
provement and for external use to demonstrate ac-
countability to the public and other interested stake-
holders. Performance measurement benefits health
care institutions by providing evidence-based, data-
driven mechanisms that generate a continuous stream
of performance information. This enables health care
institutions to understand how well their organisation is
doing over time and have continuous access to objec-
tive data to support claims of quality. The institutions
can verify the effectiveness of corrective actions; identi-
fy areas of excellence within the institution; and com-
pare their performance with that of peer institutions us-
ing the same measures. Similarly, performance data can
be used by external stakeholders to make value-based
decisions on where to seek quality health care9. They
may provide a basis for defining centres of reference in
Europe, especially for rare diseases.
Through its proposed accreditation system the OECI
seeks to address concerns of citizens and to promote
health protection and improvement, over time. As a re-
sult it will promote the following principles: 
The focus is on the patient The comments and level of
satisfaction of patients and other users of healthcare or-
ganisations are taken into account during the elabora-
tion of the Assessment tool and will continue to be tak-
en into account in its future use.
Improvement in safety of care Safety is one of the ma-
jor dimensions of quality of care, and one of the main
expectations of patients. In parallel to the increase in ef-
ficacy and complexity of hospital care over the last few
decades, there has been a comparable increase in po-
tential risk to the individual. Risk prevention depends
on a number of factors, including compliance with safe-
ty regulations and good practice, and the establishment
of a system of assessment and improvement based on
identifying risk areas and taking preventive action.
Continuous quality improvement In order to achieve
continuous quality improvement, a recognised quality
management system is required, and the AWG will pro-
mote a systematic approach to improve processes and
reduce errors based on active commitment from indi-
viduals. 
Involvement of professionals working in the healthcare
organisation Quality improvement is the result of inter-
nal initiatives implemented by the healthcare institu-
tion. It is essential that everyone participates in such
initiatives, so that they will accept changes and adopt
appropriate solutions. The various stakeholders must
be involved at every stage of the design of the accredita-
tion tool. The OECI AWG will explain, inform and com-
municate regularly with professionals.
Continuous assessment and improvement of the as-
sessment process The principles of assessment and con-
tinuous quality improvement required of health care or-
ganisations apply equally to the assessment process it-
self. The OECI AWG will work on a monitoring system to
enable it to measure efficacy, cost and any problems or
dysfunction related to the assessment process, in the
light of results obtained from pilot testing.
These principles will consequently foster responsibil-
ity and involvement of citizens regarding their health,
allowing clear, visible and transparent data throughout
Europe, thus enhancing community confidence.
The OECI accreditation project could be the founda-
tion of a new alliance between the cancer centres and
their partners in the continuous progress and search for
excellence of research and care in oncology.
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